v3.25.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 39,501,936 $ 45,816,289
Investments 13,748,473 14,395,913
Other current assets 497,294 78,869
Total current assets 53,747,703 60,291,071
Operating lease right-of-use asset 118,170 0
Total assets 53,865,873 60,291,071
Current liabilities:    
Accounts payable, accrued expenses and other current liabilities 1,583,613 2,254,300
In-process R and D accrued expenses 0 3,000,000
Total current liabilities 1,583,613 5,254,300
Operating lease liability - non-current 80,366 0
Total liabilities 1,663,979 5,254,300
Commitments and contingencies (Note 8)
Common stock, par value of $0.001 per share, 40,000,000 shares authorized, 6,127,457 and 6,102,560 shares issued and outstanding at June 30, 2025, and December 31, 2024, respectively** [1] 6,127 6,103
Additional paid-in capital 132,989,324 130,787,312
Accumulated other comprehensive income 77,577 35,992
Accumulated deficit (80,871,134) (75,792,636)
Total stockholders’ equity 52,201,894 55,036,771
Total liabilities and stockholders’ equity $ 53,865,873 $ 60,291,071
[1] Information pertaining to number of shares outstanding and per share data gives retroactive effect to a 1 for 5 reverse stock split that became effective on August 12, 2024.